155 related articles for article (PubMed ID: 5585384)
21. Studies on sulfone resistance in leprosy. 2. Treatment with a riminophenazine derivative (B.663).
Pettit JH; Rees RJ
Int J Lepr Other Mycobact Dis; 1966; 34(4):391-7. PubMed ID: 6006070
[No Abstract] [Full Text] [Related]
22. Chemotherapy of leprosy.
Leiker DL
Int J Lepr Other Mycobact Dis; 1971; 39(2):462-6. PubMed ID: 4948084
[No Abstract] [Full Text] [Related]
23. A survey of the drugs with activity against M. leprae in mice.
Shepard CC
Int J Lepr Other Mycobact Dis; 1971; 39(2):340-8. PubMed ID: 4948080
[No Abstract] [Full Text] [Related]
24. [New methods of experimental chemotherapy in leprosy].
Wagner WH
Hautarzt; 1969 Sep; 20(9):385-9. PubMed ID: 4191849
[No Abstract] [Full Text] [Related]
25. B.663 (Geigy 30. 320) in the treatment of leprosy. A preliminary report.
Devadason C
Acta Trop; 1969; 26(3):265-9. PubMed ID: 4391239
[No Abstract] [Full Text] [Related]
26. A preliminary report on the use of B663 in the treatment of Chinese leprosy patients with chronic reaction.
Warren AG
Lepr Rev; 1968 Apr; 39(2):61-6. PubMed ID: 5653308
[No Abstract] [Full Text] [Related]
27. Lamprene: first results of treatment in the Netherlands in a group of 6 leprosy patients.
Hogerzeil LM
Dermatologica; 1971; 143(6):339-44. PubMed ID: 5150817
[No Abstract] [Full Text] [Related]
28. The activity of various antituberculous drugs in suppressing experimental Mycobacterium leprae infection in mice.
Hilson GR; Banerjee DK; Holmes IB
Int J Lepr Other Mycobact Dis; 1971; 39(2):349-53. PubMed ID: 5169803
[No Abstract] [Full Text] [Related]
29. Co-incident (simultaneous) dapsone sensitive and dapsone resistant leprosy.
McDougall AC; Ross WF
Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):214-5. PubMed ID: 6749709
[No Abstract] [Full Text] [Related]
30. Dapsone-resistant leprosy.
Friedmann PS
Proc R Soc Med; 1973 Jul; 66(7):623-4. PubMed ID: 4741388
[No Abstract] [Full Text] [Related]
31. [Recurrence and resistance in 1030 leprosy patients undergoing monotherapy with dapsone].
Rollier R; Amrani-Joutey H; Belamhmer MF; Rollier B; Rollier M
Acta Leprol; 1986; 4(4):413-4. PubMed ID: 3296611
[No Abstract] [Full Text] [Related]
32. Summary of recent abstracts. 8. Leprosy.
Browne SG
Trop Dis Bull; 1971 Sep; 68(9):1021-30. PubMed ID: 4943397
[No Abstract] [Full Text] [Related]
33. Clofazimine in leprosy.
Schulz EJ
Br Med J; 1972 Mar; 1(5802):749. PubMed ID: 5015339
[No Abstract] [Full Text] [Related]
34. Dapsone-resistant leprosy.
Almeida JG; Chacko CJ
Lepr Rev; 1984 Jun; 55(2):183. PubMed ID: 6379353
[No Abstract] [Full Text] [Related]
35. The treatment of leprosy in Papua New Guinea.
Reé GH
P N G Med J; 1982 Sep; 25(3):142. PubMed ID: 6961638
[No Abstract] [Full Text] [Related]
36. Antimicrobial activity of the leprostatic drug 3-(p-chloranilino)-10-(p-chlorphenyl-2,10-dihydro-2-(isopropylimino)-phenazine (G 30'320, B. 663).
Vischer WA
Arzneimittelforschung; 1970 May; 20(5):714-23. PubMed ID: 4988610
[No Abstract] [Full Text] [Related]
37. The problem of dapsone-resistant leprosy.
Pearson JM
Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):417-20. PubMed ID: 7042605
[No Abstract] [Full Text] [Related]
38. [Advances in the chemotherapy of leprosy].
Grosset J
Med Trop (Mars); 1984; 44(1):17-22. PubMed ID: 6377002
[TBL] [Abstract][Full Text] [Related]
39. [Trial of a new leprostatics (B-663) in the treatment of lepromatous leprosy].
Renders A
Ann Soc Belges Med Trop Parasitol Mycol; 1968; 48(6):625-35. PubMed ID: 5759964
[No Abstract] [Full Text] [Related]
40. Dapsone-resistant leprosy-the THELEP approach.
Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):421-5. PubMed ID: 7042606
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
